[,] GLP-1 receptor agonists are currently classified as Food and Drug Administration (FDA) pregnancy category C, indicating that while animal studies have shown adverse fetal effects, adequate and well-controlled studies in pregnant women are deficient, and these agents are not recommended for use during pregnancy
GLP-1 side effects The side effect profile of GLP-1 medications is dominated by gastrointestinal symptoms
Zhang Y, Xie L, Ding X, Wang Y, Xu Y, Li D, et al
The lack of balance is particularly apparent when the patient stands upright
Use only as directed, and do not share with others
This detoxification process not only supports liver health but also contributes to clearer, healthier skin